UK: Types Of Intellectual Property Protection For Inventions And Granting Procedure

'The basics of patent law' covers key information relating to patent law, including: Types of intellectual property protection for inventions and granting procedure; Initiating proceedings; Infringement and related actions; Validity challenges, revocation actions and other procedures to remove the effect of an IP right; Trial, appeal and settlement; Remedies and costs; Assignment and licensing and the Unified Patent Court and Unitary Patent system.

The articles underpin Gowling WLG's contribution to Chambers' Global Practice Guide on Patent Litigation 2017, for which Gordon Harris and Ailsa Carter wrote the UK chapter.

Introduction

In the United Kingdom, inventions may be protected pursuant the patent system. In addition, for information with the necessary quality of confidence, the tort of breach of confidence may assist in protecting against unauthorised use.

Supplementary Protection Certificates (SPCs) enable a limited extension of patent term in respect of pharmaceutical or plant protection products in qualifying circumstances.

The grant of a patent covering the UK

In basic terms, there are two systems pursuant to which a patent may be granted covering the UK: the national system and the European system. Either system may be preceded by, or may provide the receiving office for, an application under the international system.

National patent system

Under the national system, an application is made to the UK Intellectual Property Office (UKIPO), for a 'GB' patent which covers the UK. The grant of a GB patent is governed by the UK Patents Act 1977 (the "Patents Act" or "PA") and associated legislation, with details of procedures set out in the Patents Rules 2007 (as amended) and the Manual of Patent Practice ("MPP") and guidance notes.

Any natural or legal person may apply for a patent in the UK, either alone or jointly with another, provided they are the inventor(s) or otherwise entitled to the property in it (PA s.7). The first step in the procedure for obtaining a patent is to file an application (which may declare a priority filing), thereby obtaining a date of filing. The patent application includes a written description of the invention, drawings if referred to, and (optionally at filing, failing which within 12 months) claims and an abstract. Preliminary examination, search, publication, substantive examination, grant and publication follow, assuming procedural and substantive requirements are met and the requisite fees paid. The term of patent protection is 20 years from the date of filing the application, provided renewal fees are paid.

It is possible for third parties to make observations in writing to the Comptroller-General of Patents, Designs and Trade Marks (the "Comptroller") about the patentability of a published application before grant (PA s.21). The UKIPO recommends that any observations be filed within three months of the publication of the application, as a patent may be granted after this period. The observations must be duly considered and in the usual course a copy of them must be provided to the applicant. A person does not become a party to any proceedings by making observations.

Appeal against a refusal by the UKIPO to grant a national patent lies to the Patents Court (a specialist list within the Chancery Division of the High Court of England and Wales) or, where applicable, Scotland's Court of Session (PA s.97).

It is permissible to apply for a national patent without using a professional representative but this is not recommended. The application process usually takes approximately three to five years from the date of filing the application, but can be considerably quicker than this if some fees are paid early and correspondence from the UK is responded to promptly.

For processing the application through to grant, UKIPO fees are usually in the region £230-300. Additional costs may be incurred by the applicant in professional services for drafting, translation and representation. These will vary greatly in accordance with the relevant circumstances.

European patent system

The European patent system (including the European Patent Office (EPO)) was established by the European Patent Convention 1973 (EPC), an international treaty made outside the remit of the European Union. It provides for the centralised application, prosecution and grant of patents (as a bundle of national designations) in and by the EPO. Aside from the EPO's remit to hear post-grant oppositions filed within the first nine months of grant, and centralised applications by the proprietor for amendment or revocation, questions of infringement and validity of each national designation are at present a matter for the courts of each relevant country.

For the grant of a patent covering the UK under the European patent system, an application is made to the EPO for a European Patent designating the UK (an 'EP(UK)'). The grant procedure (for all specified country designations) is governed by the EPC, with additional and more detailed provisions set out in the Implementing Regulations, the Rules Relating to Fees and the Guidelines for Examination in the European Patent Office.

Any natural or legal person(s) may file an application for a European patent, provided they are the inventor(s) or successor(s) in title (EPC Arts. 58 & 60). This may be the employer(s) of the inventor(s), where applicable under the law of the relevant contracting state, and an application may be filed by joint applicants. The first step in the procedure is to file an application (which may declare a priority filing), thereby obtaining a date of filing. The application must include a request for the grant of a European patent and a description and drawings (if any). Claims and an abstract must also be provided. Formalities examination, publication, search (and publication), substantive examination (by the EPO's Examining Division), and grant and publication follow, provided substantive requirements are met and the relevant fees are paid.

Following publication of the European patent application, any person may present observations concerning the patentability of the invention, which must be filed in writing in English, French or German (EPC Art.115, Implementing Rule 114). The observations are communicated to the applicant or proprietor and he may comment on them. If they call into question the patentability of the invention in whole or in part, they must be taken into account in any proceedings pending before a department of the EPO until such proceedings have been terminated. Observations will also be made available for inspection upon the start of any opposition proceedings (on which please see below).

Within nine months of grant, any person may file a written opposition to the grant of the European patent at the EPO, on one of the prescribed grounds (lack of patentability, insufficiency, added matter) (EPC Arts. 99-100). The parties' submissions in the inter partes opposition procedure are considered and decided upon by the EPO's Opposition Division, with appeal lying to a Board of Appeal. Where the opposition succeeds, or leads to the amendment of the patent, it is revoked or amended in respect of all designations for which it was granted. The EPO's decision can therefore have the effect of over-riding any amendments meanwhile made to the national designation(s) pursuant to national law and procedure.

The EPC provides also for a post-grant limitation and revocation procedure whereby the proprietor may make a central application to amend the claims of a granted patent or to revoke them. Again, the decision applies in respect of all designations for which the European patent was granted.

Appeal can be filed against a decision of a first instance division of the EPO to the EPO's Boards of Appeal. The relevant Board then acts as the department of final instance in the relevant procedure before the EPO. Reference to the Enlarged Board of Appeal is limited, essentially, to points of law and is rare.

Natural and legal applicants having either their residence or their principal place of business in a contracting state to the EPC can themselves undertake all procedural steps before the EPO and are not obliged to appoint a representative. Other applicants are, however, required to be represented by a professional representative or a legal practitioner. An association of professional representatives can also be authorised.

The process for grant of a European patent typically takes approximately three to eight years, but it can be quicker or slower than this, and opposition may lengthen the duration of EPO proceedings.

The filing and search fees due at the beginning of the application procedure for a European patent currently amount to approximately EUR 1,500, with remaining fees payable later. In total, it costs on average approximately EUR 6,000 in fees to take a patent application through to the grant stage. Additional costs may be incurred by the applicant in professional services for drafting, translation and representation, but these will vary greatly in accordance with the relevant circumstances.

At the post-grant stage, competence is transferred to the contracting states designated in the European patent. Validation procedures (which may include translations and payment of fees) must be completed in each country of interest within three months of grant. The granted European patent will only take effect in countries where it is validated. However, for the UK, pursuant to the London Agreement the translation requirements of Article 65(1) EPC have been dispensed with.

After the end of the year of grant or, if it is granted before the end of the fourth year of its term, after the end of that fourth year, annual renewal fees are payable to the UK Office in order to maintain the UK designation of a European patent (EPC Art. 86, Implementing Rules 37(4) & 38(1), PA s.77, MPP). For more on fees, please see below.

International application system

National patents and European patents covering the UK may alternatively be designated as part of a Patent Cooperation Treaty (PCT) application (an 'international application').

The international application system enables some consolidation of patent applications made internationally. The central coordination of the system is conducted by the World Intellectual Property Office (WIPO) in Geneva at the 'International Bureau'.

The filing of an international application, designating contracting states and regions for which the application is made, begins the 'international phase' of the application, in which the application will ultimately be searched against the prior art by an International Searching Authority (ISA). The purpose of the search is to discover relevant prior art. The search report and the ISA's written opinion are transmitted to the applicant and the International Bureau. The applicant may request supplemental searches. The international application is published 18 months after the claimed priority date. Applicants may optionally request substantive examination, although the resulting opinion is non-binding on national and regional offices.

If the application reaches the 'national' or 'regional' phase, then the countries (or regions) in respect of which it has entered that phase will proceed with examination.

Any resident or national of a contracting state to the PCT may file an international application. The UKIPO can act as a receiving office for an international patent application where the applicant (or one of them) is resident in the UK or the Isle of Man or is a British citizen. The EPO can act as a receiving office where the applicant is a resident or a national of a State which is a party to both the EPC and the PCT (at present all EPC states are parties to the PCT). For international applications received by the UKIPO or the EPO, the relevant ISA is the EPO.

The UKIPO deals with international applications in the national phase in the same way as a national application, with some modifications. For example, a translation is necessary where the international application was not published in English.

An international application which designates or elects the EPO is equivalent to a normal European application, again with some modifications. For example, where the international application was not published in one of English, French or German, the applicant must supply a translation of the application into one of those languages.

Fees for maintaining a patent covering the UK

Renewal fees are payable on the last day of the month in which the application for the patent was filed, from the fourth anniversary of filing onwards. The fees increase each year, currently from £70 in the fifth year to £600 in each of the twelfth to twentieth years.

The fee for each year should normally be paid within the period of three calendar months ending on the last day of the month in which the renewal date falls. If a renewal fee is not paid within the prescribed period, the patent will lapse. However, if the renewal fee and a late payment fee (currently £24) are paid within six months following the due date, the patent shall be treated as if it had never expired. After the expiry of six months following the due date, at which point the patent has ceased to have effect, the patent can only be restored by making an application to the Comptroller. If the Comptroller is satisfied that the failure to pay the renewal fee (and any late payment fee) was unintentional, he shall restore the patent upon payment.

Supplementary protection certificates

A Supplementary Protection Certificate (SPC) is a form of intellectual property right that extends patent protection in respect of pharmaceutical or plant protection products in qualifying circumstances. An SPC may be granted to the holder of the 'basic patent' (on which see below) or his successor in title.

The SPC regime is based on several key EU Regulations: 469/2009, 1901/2006, 141/2000 (medicinal products); and 1610/96 (plant protection products). However, the legislative regime includes interaction with other EU legislation and UK national law.

Article 3 of both Regulation 469/2009 (medicinal products) and Regulation 1610/96 (plant protection) provides that a certificate shall be granted if, in the Member State in which the application is submitted and at the date of that application:

  1. the product is protected by a basic patent in force;
  2. an appropriate and valid authorisation to place the product on the market has been granted;
  3. the product has not already been the subject of a certificate; and
  4. the authorisation referred to in (b) is the first authorisation to place the product on the market as a medicinal/plant protection product.

A further condition is that the holder of more than one patent for the same product shall not be granted more than one certificate for that product.

These legislative provisions have been interpreted by the Court of Justice of the European Union (CJEU), in decisions which are binding upon the courts in the UK. The case law is complex and the meaning of the above provisions remains the subject of references to the CJEU from the UK High Court. In short, and very simply, the "product" means the active ingredient or combination of active ingredients of a medicinal product; the "medicinal product" means the substance or combination of substances presented for treating or preventing disease (for example the full pharmaceutical formulation); the "basic patent" means a patent which protects a product as such, a process to obtain a product, or an application of a product.

The term of an SPC is intended to compensate, to some degree, for the period elapsing between the filing of an application for a patent and the grant of authorisation to place the relevant product on the market. The duration is equal to the patent life lost between the patent filing date and the date of first marketing authorisation in the EEA (which includes the EU), minus five years, subject to a maximum of five years.

It is possible to extend the SPC for a medicine by six months if certain studies in the paediatric population are carried out, regardless of whether the medicine is ultimately authorised for children.

For EU member states, including the UK, SPCs are granted at the national level by the relevant patent office. For the UK, this entails an application in the prescribed form to the UKIPO, irrespective of whether the basic patent is a national patent (GB) or a European patent designating the UK (EP(UK)). The application fee is currently £250. An application for a paediatric extension must also be in prescribed form and accompanied by a fee of £200.

When all requirements are met, the certificate or extension will be granted. The certificate will state the date of expiry of the maximum possible period of its duration.

The certificate takes effect at the end of the lawful term of the basic patent provided that the basic patent has not previously lapsed or been revoked, and provided the annual fees are paid in time. The annual fees are payable for each year of the effective period of the certificate as a single cumulative amount. It is not possible for an applicant to opt to pay renewal fees one year at a time on an SPC in the UK. Any final period of less than 12 months is treated as a whole year. Currently the fees for five successive years are £600, £1300, £2100, £3000 and £4000. The fees are usually payable on the date on which the certificate is due to take effect and may be paid within the previous three months. Late payment is possible up to six months after the due date subject to an additional fee of one half of the amount of the unpaid fees; the annual fees will then be treated as having been filed on the due date.

If fees are not paid, the certificate will be treated as having lapsed on the date of expiry of the basic patent and so will not take effect.

Rights conferred by a patent covering the UK

The grant of a patent, whether a national patent or a European patent designating the UK, is the grant to the proprietor, for the term of the patent, of a monopoly right in respect of the patented invention.

The scope of the monopoly right conferred by the grant of a patent is defined by the Patents Act: it is limited to acts which infringe the patent pursuant to section 60.

Where the court is satisfied that a third party's acts infringe (or would infringe) the patent, the court will, in the usual course, award relief to remedy the statutory tort of infringement (as discussed in section F below).

The existence of a patent does not entitle the proprietor to relief; it is the order of the court, following a finding of infringement (or threatened infringement) which enables the proprietor of a patent to protect the monopoly conferred by the grant of that patent. Interim relief and other measures (such as disclosure, and seizure) are similarly available only by way of court order, following an application to the court and a conclusion by the court, upon the relevant facts, that such interim relief should be awarded.

Protection against breach of confidence

Know-how and trade secrets may be protected by an obligation of confidentiality arising under the common law or because of specific contractual terms (for example, employment contracts and non-disclosure agreements may include such terms).

Pursuant to the English common law (Coco v Clark (1969) RPC 41; Saltman v Campbell [1963] 3 All ER 413; BBC v HarperCollins [2010] EWHC 2424 (Ch)), it is a tort to use in an unauthorised manner, to the detriment of the originating party, information which has the necessary quality of confidence and is subject to an obligation of confidence. To have the necessary quality of confidence, the information must not be in the public domain or form part of an employee's general skill and knowledge. The requisite obligation of confidence may exist pursuant to a contractual obligation or the circumstances in which it was imparted.

Breach of a contractual term of confidence may also give rise to a claim for breach of contract.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Events from this Firm
16 Jan 2018, Seminar, Birmingham, UK

Join Gowling WLG's pensions team as they explain some of the biggest challenges facing trustees and employers in the coming year and provide practical ways of dealing with them.

23 Jan 2018, Seminar, London, UK

Join Gowling WLG's pensions team as they explain some of the biggest challenges facing trustees and employers in the coming year and provide practical ways of dealing with them.

25 Jan 2018, Seminar, Birmingham, UK

2018 is set to be another big year in employment, with employers set to face new challenges and responsibilities. At our event, looking ahead to next year, we will be discussing four key issues you might face in 2018, providing useful tips and answering your questions.

 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

    Disclaimer

    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

    Registration

    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

    Cookies

    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

    Links

    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

    Mail-A-Friend

    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

    Emails

    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

    Security

    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions